Intermittent androgen deprivation in advanced prostate cancer

Urol Res. 1997:25 Suppl 2:S63-6. doi: 10.1007/BF00941990.
No abstract available

Publication types

  • Review

MeSH terms

  • Aged
  • Androgen Antagonists / administration & dosage
  • Androgen Antagonists / therapeutic use*
  • Animals
  • Apoptosis / drug effects
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Drug Administration Schedule
  • Humans
  • Male
  • Neoplasms, Hormone-Dependent / blood
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Neoplasms, Hormone-Dependent / pathology
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Quality of Life

Substances

  • Androgen Antagonists
  • Prostate-Specific Antigen